STOCK TITAN

[SCHEDULE 13G/A] Centene Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Harris Associates L.P. and Harris Associates, Inc. file Amendment No. 1 to a Schedule 13G reporting ownership in Centene Corp. The filing shows Harris beneficially owns 20,418,731 shares of Centene common stock, representing 4.1% of the class. Harris reports sole voting power for 18,043,616 shares and sole dispositive power for 20,418,731 shares. The filing states these shares are held in the ordinary course of business and not for the purpose of changing control. The document identifies the filing parties, addresses, CUSIP 15135B101, and includes certifications and signatures dated 08/14/2025.

Harris Associates L.P. e Harris Associates, Inc. presentano l'Emendamento n. 1 al modulo Schedule 13G relativo alla partecipazione in Centene Corp. La dichiarazione indica che Harris detiene beneficiariamente 20.418.731 azioni ordinarie di Centene, corrispondenti al 4,1% della classe. Harris dichiara di avere la piena facoltà di voto su 18.043.616 azioni e la piena facoltà dispositiva su 20.418.731 azioni. Il documento precisa che tali azioni sono detenute nell'ambito normale dell'attività e non con l'intento di modificare il controllo. Il deposito riporta le parti firmatarie, gli indirizzi, il CUSIP 15135B101 e contiene certificazioni e firme datate 14/08/2025.

Harris Associates L.P. y Harris Associates, Inc. presentan la Enmienda nº 1 al Schedule 13G que informa sobre la participación en Centene Corp. La presentación muestra que Harris posee a título beneficioso 20.418.731 acciones ordinarias de Centene, lo que representa el 4,1% de la clase. Harris declara tener el poder de voto exclusivo sobre 18.043.616 acciones y el poder dispositvo exclusivo sobre 20.418.731 acciones. El documento indica que estas acciones se mantienen en el curso ordinario del negocio y no con el propósito de cambiar el control. El expediente identifica a las partes que presentan, las direcciones, el CUSIP 15135B101 e incluye certificaciones y firmas fechadas el 14/08/2025.

Harris Associates L.P.와 Harris Associates, Inc.가 Centene Corp. 지분 관련 Schedule 13G 수정서(Amendment No. 1)를 제출했습니다. 제출서에 따르면 Harris는 Centene 보통주 20,418,731주를 실질적으로 보유하고 있으며 이는 해당 종목의 4.1%에 해당합니다. Harris는 18,043,616주에 대한 단독 의결권20,418,731주에 대한 단독 처분권을 보유하고 있다고 보고했습니다. 제출서에는 이러한 주식이 영업의 일상적 과정에서 보유된 것이며 지배권 변경을 목적으로 하지 않았다고 명시되어 있습니다. 문서에는 제출 당사자, 주소, CUSIP 15135B101이 기재되어 있으며 2025년 8월 14일자 인증 및 서명이 포함되어 있습니다.

Harris Associates L.P. et Harris Associates, Inc. déposent l'Amendement n°1 au Schedule 13G signalant une participation dans Centene Corp. Le dépôt indique que Harris détient à titre bénéficiaire 20 418 731 actions ordinaires de Centene, représentant 4,1 % de la catégorie. Harris déclare disposer du pouvoir de vote exclusif sur 18 043 616 actions et du pouvoir discrétionnaire exclusif sur 20 418 731 actions. Le document précise que ces actions sont détenues dans le cours normal des affaires et non dans le but de modifier le contrôle. Le dossier identifie les parties déposantes, les adresses, le CUSIP 15135B101 et comprend des certifications et signatures datées du 14/08/2025.

Harris Associates L.P. und Harris Associates, Inc. reichen Nachtrag Nr. 1 zum Schedule 13G ein, der die Beteiligung an Centene Corp. meldet. Die Einreichung zeigt, dass Harris wirtschaftlich 20.418.731 Aktien von Centene hält, was 4,1% der Aktienklasse entspricht. Harris gibt an, alleinige Stimmrechte für 18.043.616 Aktien und alleinige Verfügungsgewalt über 20.418.731 Aktien zu besitzen. In der Erklärung heißt es, diese Aktien würden im normalen Geschäftsverlauf gehalten und nicht mit dem Ziel, die Kontrolle zu ändern. Das Dokument nennt die einreichenden Parteien, Adressen, CUSIP 15135B101 und enthält Zertifizierungen und Unterschriften datiert auf den 14.08.2025.

Positive
  • Clear disclosure of beneficial ownership: 20,418,731 shares reported
  • Explicit certification that shares are held in the ordinary course and not to change control
Negative
  • None.

Insights

TL;DR: Harris reports a passive 4.1% stake in Centene, with material voting and dispositive authority but no stated intent to influence control.

The reported 20,418,731-share position (4.1% of outstanding) is sizable enough to be noticed by investors but remains below common 5% significance thresholds for many disclosures. Sole voting power of 18,043,616 shares indicates Harris can direct votes on most of the position it controls, while dispositive power over the full reported stake shows investment discretion. The filing repeatedly affirms holdings are in the ordinary course of business and not intended to effect control, which frames this as an advisory/asset-management ownership rather than an activist stake.

TL;DR: Governance impact appears limited; the filer asserts non-control intent despite significant voting power.

The Schedule 13G/A discloses concentrated economic and voting exposure but includes the standard certification that the position is not held to change or influence control. From a governance perspective, the presence of sole voting power over most of the shares means Harris could influence routine shareholder votes if it chose to, but the filing’s explicit statement of ordinary-course holdings reduces immediate signaling of activist intent. No group affiliations or additional arrangements are reported.

Harris Associates L.P. e Harris Associates, Inc. presentano l'Emendamento n. 1 al modulo Schedule 13G relativo alla partecipazione in Centene Corp. La dichiarazione indica che Harris detiene beneficiariamente 20.418.731 azioni ordinarie di Centene, corrispondenti al 4,1% della classe. Harris dichiara di avere la piena facoltà di voto su 18.043.616 azioni e la piena facoltà dispositiva su 20.418.731 azioni. Il documento precisa che tali azioni sono detenute nell'ambito normale dell'attività e non con l'intento di modificare il controllo. Il deposito riporta le parti firmatarie, gli indirizzi, il CUSIP 15135B101 e contiene certificazioni e firme datate 14/08/2025.

Harris Associates L.P. y Harris Associates, Inc. presentan la Enmienda nº 1 al Schedule 13G que informa sobre la participación en Centene Corp. La presentación muestra que Harris posee a título beneficioso 20.418.731 acciones ordinarias de Centene, lo que representa el 4,1% de la clase. Harris declara tener el poder de voto exclusivo sobre 18.043.616 acciones y el poder dispositvo exclusivo sobre 20.418.731 acciones. El documento indica que estas acciones se mantienen en el curso ordinario del negocio y no con el propósito de cambiar el control. El expediente identifica a las partes que presentan, las direcciones, el CUSIP 15135B101 e incluye certificaciones y firmas fechadas el 14/08/2025.

Harris Associates L.P.와 Harris Associates, Inc.가 Centene Corp. 지분 관련 Schedule 13G 수정서(Amendment No. 1)를 제출했습니다. 제출서에 따르면 Harris는 Centene 보통주 20,418,731주를 실질적으로 보유하고 있으며 이는 해당 종목의 4.1%에 해당합니다. Harris는 18,043,616주에 대한 단독 의결권20,418,731주에 대한 단독 처분권을 보유하고 있다고 보고했습니다. 제출서에는 이러한 주식이 영업의 일상적 과정에서 보유된 것이며 지배권 변경을 목적으로 하지 않았다고 명시되어 있습니다. 문서에는 제출 당사자, 주소, CUSIP 15135B101이 기재되어 있으며 2025년 8월 14일자 인증 및 서명이 포함되어 있습니다.

Harris Associates L.P. et Harris Associates, Inc. déposent l'Amendement n°1 au Schedule 13G signalant une participation dans Centene Corp. Le dépôt indique que Harris détient à titre bénéficiaire 20 418 731 actions ordinaires de Centene, représentant 4,1 % de la catégorie. Harris déclare disposer du pouvoir de vote exclusif sur 18 043 616 actions et du pouvoir discrétionnaire exclusif sur 20 418 731 actions. Le document précise que ces actions sont détenues dans le cours normal des affaires et non dans le but de modifier le contrôle. Le dossier identifie les parties déposantes, les adresses, le CUSIP 15135B101 et comprend des certifications et signatures datées du 14/08/2025.

Harris Associates L.P. und Harris Associates, Inc. reichen Nachtrag Nr. 1 zum Schedule 13G ein, der die Beteiligung an Centene Corp. meldet. Die Einreichung zeigt, dass Harris wirtschaftlich 20.418.731 Aktien von Centene hält, was 4,1% der Aktienklasse entspricht. Harris gibt an, alleinige Stimmrechte für 18.043.616 Aktien und alleinige Verfügungsgewalt über 20.418.731 Aktien zu besitzen. In der Erklärung heißt es, diese Aktien würden im normalen Geschäftsverlauf gehalten und nicht mit dem Ziel, die Kontrolle zu ändern. Das Dokument nennt die einreichenden Parteien, Adressen, CUSIP 15135B101 und enthält Zertifizierungen und Unterschriften datiert auf den 14.08.2025.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



HARRIS ASSOCIATES L P
Signature:Joseph J. Allessie
Name/Title:Joseph J. Allessie, General Counsel and Secretary
Date:08/14/2025
Harris Associates, Inc.
Signature:Joseph J. Allessie
Name/Title:Joseph J. Allessie, General Counsel and Secretary
Date:08/14/2025

FAQ

How many Centene (CNC) shares does Harris Associates report owning?

The filing reports 20,418,731 shares, representing 4.1% of the class.

What voting power does Harris Associates hold in Centene (CNC)?

Harris reports sole voting power over 18,043,616 shares and sole dispositive power over 20,418,731 shares.

Does the Schedule 13G/A indicate Harris Associates seeks to change Centene's control?

No. The filing certifies the shares are acquired and held in the ordinary course of business and not to change or influence control.

What is the CUSIP for the reported Centene shares?

The CUSIP reported in the filing is 15135B101.

When was the Schedule 13G/A signed?

Signatures on the filing are dated 08/14/2025.
Centene Corp Del

NYSE:CNC

CNC Rankings

CNC Latest News

CNC Latest SEC Filings

CNC Stock Data

13.29B
488.78M
0.46%
101.12%
2.74%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
ST LOUIS